Gene analysis -
Testing cancer risk
Oncological gene analysis allows the early determination of cancer risks. This involves the identification of cell mutations and gene changes, which have a known connection to the development of cancer. Such cancer risk tests facilitate timely and targeted precautionary measures and allow therapy optimisation through the precise classification of the respective cancer.
If there are hereditary cancers in your family, you can determine whether you are affected through gene analysis. Screening programmes which are specially tailored to you reduce the risk of developing cancer. Genetic changes in the tumour tissue are often the basis for using a target-oriented and thus most-effective therapy with few side-effects.
Areas of application
- Human genetic counselling for cancer patients and their relatives with regard to genetic predisposition to cancers.
- Molecular genetic testing (MLH1, MSH2) for patients with colorectal cancer and uterine cancer.
- Molecular genetic testing (BRCA1, BRCA2) for patients with ovarian cancer and breast cancer.
- Compilation of tailored screening programmes, which take genetic risk and general cancer risk into account.
- Molecular genetic testing of tumours with relevance to diagnosis and therapy.
- Psychological counselling for cancer patients and high cancer risk patients.
- Nutritional counselling for cancer patients
Find out now whether you have a predisposition to cancer!
You can obtain more detailed information on gene analysis from our telephone info-line or by email. All contact details can be found on our Contact page.